SEC Clinical Research LLC

Clinical research site in Andalusia, Alabama · 822 S THREE NOTCH ST STE B, ANDALUSIA, AL 36420-5310 · (334) 504-7014

As of July 2026, 1 paid clinical trial is recruiting at SEC Clinical Research LLC in Andalusia, Alabama. Active studies at this site focus on Cardiovascular Disease and Lipoprotein(a) alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at SEC Clinical Research LLC (1)

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

for Cardiovascular Disease and Lipoprotein(a)

120 locations incl. Andalusia

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 100

Code: NCT07517263·Phase 3·Recruiting·Listed Apr 2026

Apply to this trial

Explore more

Paid clinical trials in Andalusia, AL · Alabama clinical trials